These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15588496)

  • 1. Expression profiling of cardiovascular disease.
    Archacki S; Wang Q
    Hum Genomics; 2004 Aug; 1(5):355-70. PubMed ID: 15588496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of cardiovascular diseases.
    Archacki SR; Wang QK
    Methods Mol Med; 2006; 129():1-13. PubMed ID: 17085801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases.
    Nanni L; Romualdi C; Maseri A; Lanfranchi G
    J Mol Cell Cardiol; 2006 Dec; 41(6):934-48. PubMed ID: 17020763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure?
    Gora M; Kiliszek M; Burzynska B
    Curr Genomics; 2013 Sep; 14(6):388-96. PubMed ID: 24396272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?
    Marziliano N; Grasso M; Pilotto A; Porcu E; Tagliani M; Disabella E; Diegoli M; Pasotti M; Favalli V; Serio A; Gambarin F; Tavazzi L; Klersy C; Arbustini E
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):433-42. PubMed ID: 19449458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease.
    Kittleson MM; Hare JM
    Trends Cardiovasc Med; 2005 May; 15(4):130-8. PubMed ID: 16099376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications.
    Seo D; Ginsburg GS; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2006 Jul; 48(2):227-35. PubMed ID: 16843168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray, SAGE and their applications to cardiovascular diseases.
    Ye SQ; Lavoie T; Usher DC; Zhang LQ
    Cell Res; 2002 Jun; 12(2):105-15. PubMed ID: 12118936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial analysis of gene expression: technical considerations and applications to cardiovascular biology.
    Patino WD; Mian OY; Hwang PM
    Circ Res; 2002 Oct; 91(7):565-9. PubMed ID: 12364383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of gene expression profile of cardiovascular diseases].
    Wang RL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):483-5. PubMed ID: 16134614
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic contributors toward increased risk for ischemic heart disease.
    Nordlie MA; Wold LE; Kloner RA
    J Mol Cell Cardiol; 2005 Oct; 39(4):667-79. PubMed ID: 16087188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
    Wongsurawat T; Woo CC; Giannakakis A; Lin XY; Cheow ESH; Lee CN; Richards M; Sze SK; Nookaew I; Kuznetsov VA; Sorokin V
    Atherosclerosis; 2018 Apr; 271():237-244. PubMed ID: 29395098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.
    Marchetti G; Girelli D; Zerbinati C; Lunghi B; Friso S; Meneghetti S; Coen M; Gagliano T; Guastella G; Bochaton-Piallat ML; Pizzolo F; Mascoli F; Malerba G; Bovolenta M; Ferracin M; Olivieri O; Bernardi F; Martinelli N
    Thromb Haemost; 2015 Mar; 113(3):655-63. PubMed ID: 25374339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of microarrays in the search of gene expression patterns: application to the study of complex phenotypes].
    Guindalini C; Tufik S
    Braz J Psychiatry; 2007 Dec; 29(4):370-4. PubMed ID: 18200399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of altered genomic expression profiles in the senescent and diseased myocardium using cDNA microarrays.
    Juhasz O; Zhu Y; Garg R; Anisimov SV; Boheler KR
    Eur J Heart Fail; 2002 Dec; 4(6):687-97. PubMed ID: 12453538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.
    Chen FC; Brozovich FV
    J Vasc Res; 2008; 45(5):445-54. PubMed ID: 18418003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of mouse aorta and cultured vascular smooth muscle cells differ widely, yet show common responses to dioxin exposure.
    Puga A; Sartor MA; Huang MY; Kerzee JK; Wei YD; Tomlinson CR; Baxter CS; Medvedovic M
    Cardiovasc Toxicol; 2004; 4(4):385-404. PubMed ID: 15531781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA microarrays: implications for cardiovascular medicine.
    Cook SA; Rosenzweig A
    Circ Res; 2002 Oct; 91(7):559-64. PubMed ID: 12364382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.